Issue Cover

News & Columns

Articles

article-item
6-7 News

Roche and Ascidian agree to $1.8bn neurological disease partnership

18 March 2025News & Columns
article-item
8-9 News

Researchers identify new major cause of inflammatory bowel disease

18 March 2025News & Columns
article-item
10-11 Dermatology News

UCB’s Bimzelx approved by MHRA for hidradenitis suppurativa

18 March 2025News & Columns
article-item
12 DARWIN'S MEDICINE - Innovation’s one real law

The evolutionary lessons for Bayer’s management restructure

18 March 2025News & Columns
article-item
13 MIKE DIXON - The importance of the human touch in today’s AI world

Collecting the right data in the right way for the right reasons

18 March 2025News & Columns
article-item
14 INNOVATIVE IMPACT BLOG - THE AI ADVANTAGE: SEVEN STEPS TO AUGMENTED PHARMA BRAND PLANNING

How much time do you spend thinking about the impact of what is working and what is not in today’s organisational reality, versus what was captured in the situational analysis in your brand plan?

18 March 2025News & Columns
article-item
15 HEALTHCARE COMMUNICATIONS - IS CRITICAL THINKING AT RISK?
18 March 2025News & Columns
article-item
News

Roche and Ascidian agree to $1.8bn neurological disease partnership

20 February 2025News & Columns
article-item
News

Researchers identify new major cause of inflammatory bowel disease

20 February 2025News & Columns
article-item
Dermatology News

UCB’s Bimzelx approved by MHRA for hidradenitis suppurativa

20 February 2025News & Columns
article-item
DARWIN'S MEDICINE - Astrategia

The evolutionary lessons for Bayer’s management restructure

20 February 2025News & Columns
article-item
MIKE DIXON - What is it all for?

Collecting the right data in the right way for the right reasons

20 February 2025News & Columns